Robeco Institutional Asset Management B.V. Acquires 2,532 Shares of MAXIMUS, Inc. (NYSE:MMS)

Robeco Institutional Asset Management B.V. grew its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 6.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 42,882 shares of the health services provider’s stock after acquiring an additional 2,532 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.07% of MAXIMUS worth $3,110,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in MMS. 6 Meridian increased its stake in MAXIMUS by 2.3% in the second quarter. 6 Meridian now owns 7,045 shares of the health services provider’s stock valued at $511,000 after purchasing an additional 157 shares in the last quarter. Chatham Capital Group Inc. increased its stake in MAXIMUS by 0.7% in the first quarter. Chatham Capital Group Inc. now owns 32,850 shares of the health services provider’s stock valued at $2,332,000 after purchasing an additional 241 shares in the last quarter. Advisor Group Inc. increased its stake in MAXIMUS by 47.3% in the fourth quarter. Advisor Group Inc. now owns 869 shares of the health services provider’s stock valued at $56,000 after purchasing an additional 279 shares in the last quarter. First National Bank of Omaha increased its stake in MAXIMUS by 5.2% in the first quarter. First National Bank of Omaha now owns 5,792 shares of the health services provider’s stock valued at $411,000 after purchasing an additional 284 shares in the last quarter. Finally, BB&T Corp grew its holdings in shares of MAXIMUS by 3.6% during the first quarter. BB&T Corp now owns 8,432 shares of the health services provider’s stock valued at $598,000 after buying an additional 291 shares during the last quarter. 94.12% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have recently issued reports on MMS shares. ValuEngine cut shares of MAXIMUS from a “buy” rating to a “hold” rating in a report on Friday, June 28th. Zacks Investment Research upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a report on Monday, May 27th.

Shares of NYSE MMS traded up $0.61 during mid-day trading on Wednesday, reaching $70.84. 30,059 shares of the company’s stock traded hands, compared to its average volume of 216,451. The company has a market capitalization of $4.57 billion, a PE ratio of 20.84, a P/E/G ratio of 1.93 and a beta of 0.88. The business has a 50-day moving average of $73.52. MAXIMUS, Inc. has a 1-year low of $60.00 and a 1-year high of $76.84. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.31 and a current ratio of 2.31.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Thursday, May 9th. The health services provider reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. MAXIMUS had a net margin of 8.76% and a return on equity of 21.19%. The firm had revenue of $736.50 million during the quarter, compared to analysts’ expectations of $757.29 million. During the same period last year, the company earned $0.84 earnings per share. The business’s revenue was up 20.2% on a year-over-year basis. As a group, sell-side analysts anticipate that MAXIMUS, Inc. will post 3.7 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Thursday, August 15th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend is Wednesday, August 14th. MAXIMUS’s dividend payout ratio (DPR) is presently 29.41%.

In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $72.90, for a total value of $72,900.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Vice Chairman Richard A. Montoni sold 12,000 shares of MAXIMUS stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $74.07, for a total transaction of $888,840.00. Following the completion of the sale, the insider now directly owns 377,874 shares in the company, valued at approximately $27,989,127.18. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,000 shares of company stock worth $3,575,540. 2.20% of the stock is owned by corporate insiders.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

See Also: 52-Week High/Low Prices For Stock Selection

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.